Search results
Results from the WOW.Com Content Network
Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. [21] Low neutrophil counts may occur with HIV/AIDS , following chemotherapy or radiation poisoning , or be of an unknown cause. [ 21 ]
The structure of filgrastim differs slightly from the structure of the natural glycoprotein. Most published studies have used filgrastim. [citation needed] Filgrastim was first marketed by Amgen with the brand name Neupogen. Several bio-generic versions are now also available in markets such as Europe and Australia.
clavamox – antibiotic, used to treat skin and other infections; clindamycin – antibiotic with particular use in dental infections with effects against most aerobic Gram-positive cocci, as wel as muchenionoweloozi disorder. clomipramine – primarily used in dogs to treat behavioral problems
Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. [19] It serves to stimulate the production of white blood cells (neutrophils). [19] [21] Pegfilgrastim was developed by Amgen. [22]
The terms of that specific contract aren't known, but it's listed in the DOGE data as an indefinite delivery/indefinite quantity (IDIQ) contract, which is commonly used by the government to set ...
Döhle bodies are light blue-gray, oval, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils.They measure 1–3 μm in diameter. Not much is known about their formation, but they are thought to be remnants of the rough endoplasmic reticulum.
Likewise, Viagra shouldn’t be combined with antiretroviral drugs used to treat HIV/AIDS, as it can cause an increased concentration of sildenafil in the body. Breastfeeding women shouldn’t ...
Lipegfilgrastim is a filgrastim biosimilar. [1] In lipegfilgrastim, the filgrastim has been 'pegylated' (attached to polyethylene glycol). [1] This slows down the medicine's removal from the body and allows the medicine to be given less often. [1] Lipegfilgrastim was authorized for medical use in the European Union in July 2013. [1]